1.Effects of Jur ur-4 granules on a Type 2 Diabetes Mellitus rat Model
Anu A ; Myadagbadam U ; Chimedragchaa Ch
Mongolian Journal of Health Sciences 2025;87(3):60-64
		                        		
		                        			Background:
		                        			In traditional medicine, Jur Ur-4 Tang, which is widely
used for the treatment of diabetes, has been technologically processed
and transformed into a modern pharmaceutical form as soluble granules.
Therefore, it is essential to evaluate the pharmacological effects
of the soluble granules derived from Jur Ur-4 Tang.
		                        		
		                        			Aim:
		                        			To study the
effect of granules extracted from Jur ur-4 Tang in a model of type 2 diabetes
mellitus in experimental rats.
		                        		
		                        			:
		                        			Materials and Methods
		                        		
		                        			:
		                        			T2DM in
rats was induced by a high-fat diet and a low-dose streptozotocin (STZ
35 mg/kg). Then, oral gavage administration of three different doses
of Granule (450 mg/kg, 900 mg/kg) was given to T2DM rats. Experimental
results showed that Granule dramatically reduced the levels
of fasting blood glucose, fasting blood insulin, and GLUT4.
		                        		
		                        			Results::
		                        			In the glucose tolerance test, granules at doses of 450 and 900 mg/
kg significantly reduced blood glucose levels at 60 and 120 minutes
(p < 0.01). Additionally, the soluble granules at all tested doses significantly
decreased blood insulin levels and increased GLUT4 expression
(p<0.01).
		                        		
		                        			Conclusion
		                        			The granules lower blood glucose levels.
		                        		
		                        		
		                        		
		                        	
2.Risk of cardiovascular disease in Mongolian patients with rheumatoid arthritis
Anu G ; Tsolmon D ; Devshil Z ; Altanzul B ; Chingerel Kh ; Zulgerel D
Mongolian Journal of Health Sciences 2025;85(1):115-119
		                        		
		                        			 Background:
		                        			Patients with rheumatoid arthritis are at increased risk of developing cardiovascular disease. In Mongolia, 
the registration of inflammatory diseases is increasing every year, and cardiovascular diseases are the leading cause of 
death. 
		                        		
		                        			Aim:
		                        			We aimed to determine the degree of cardiovascular risk and its correlation in people with rheumatoid arthritis. 
		                        		
		                        			Materials and Methods:
		                        			 The study was conducted in a cross-sectional study design with 64 patients with rheumatoid 
arthritis between May and November 2024. Cardiovascular risk was assessed using mSCORE and the World Health Organization (WHO) cardiovascular Risk Table. We received ethical approval to begin the research at the MNUMS meeting 
on May 17, 2024 (No. 2024/3-05).
		                        		
		                        			 Results:
		                        			The average age of the participants was 55.2±9.7 years, and the average duration since being diagnosed with RA 
was 9.8±8.0 years. Among the participants, 82.8% (n=53) were female, and 17.2% (n=11) were male. The mean WHO 
risk index was 10.25±11, while the mean mSCORE risk index was 2.9±4 (p=0.001). There was a significant difference in 
mSCORE scores between the 40-55 and 56-65 age groups (p<0.001). In contrast, the mSCORE risk assessment showed 
that 15.6% (n=10) had high risk, and 6.3% (n=4) had very high risk. Among the parameters of inflammatory biomarkers, 
CRP (OR=0.05, r=0.35, 95% CI 0.9-3.2, p=0.004) has a statistically significant difference and positive correlation, and 
HDL-C (OR=2.3, r=-0.25, 95% CI 2.9- 10.0, p<0.0001) was significantly different and negatively correlated. 
		                        		
		                        			Conclusion
		                        			A total of 64 participants participated in our study, and according to the WHO assessment, 17.2% were at 
high or very high risk of developing cardiovascular disease in the next 10 years, and according to the mSCORE, 21.9% 
were at high or very high risk of developing cardiovascular disease. Although the degree of disease activity was not significantly associated with cardiovascular risk, the inflammatory biomarker C-reactive protein was statistically significantly different or positively associated with cardiovascular risk assessment.
		                        		
		                        		
		                        		
		                        	
3.CSF1R-Related Adult-Onset Leukoencephalopathy With Axonal Spheroids: A Case Series of Four Asian Indian Patients
Divyani GARG ; Abhishek VAINGANKAR ; Anu GUPTA ; Roopa RAJAN ; Ajay GARG ; Ayush AGARWAL ; Farsana MUSTAFA ; Divya M RADHAKRISHNAN ; Awadh Kishor PANDIT ; Venugopalan Y VISHNU ; Mamta Bhushan SINGH ; Rohit BHATIA ; Achal Kumar SRIVASTAVA
Journal of Movement Disorders 2025;18(2):170-174
		                        		
		                        			 Objective:
		                        			Colony-stimulating factor 1 receptor-related leukoencephalopathy (CSF1R-L) is a rare adult-onset leukoencephalopathy. Reports of CSF1R-L patients from the Indian subcontinent remain limited. We aimed to report four patients with genetically confirmed CSF1R-L from four Asian Indian families and described their clinical, molecular, and radiological features. 
		                        		
		                        			Methods:
		                        			All patients underwent clinical examination, brain magnetic resonance imaging, and whole-exome sequencing to identify causative variants in the CSF1R gene. We also reviewed published reports of Indian patients with CSF1R-L. 
		                        		
		                        			Results:
		                        			The age at enrollment ranged from 34 to 40 years. The duration of symptoms ranged from 11 months to 2 years. The chief clinical phenotype in three patients was a rapidly evolving cognitive-behavioral syndrome combined with atypical parkinsonism, and asymmetrical spastic tetraparesis was observed in one patient. We identified four different variants (three missense variants and one in-frame deletion). Radiological findings revealed white matter involvement and diffusion restriction involving the subcortical white matter and pyramidal tracts. 
		                        		
		                        			Conclusion
		                        			We expand the literature on CSF1R-L patients from India by reporting four new cases. 
		                        		
		                        		
		                        		
		                        	
4.Propensity score analysis of adjuvant therapy in radically resected gallbladder cancers: A real world experience from a regional cancer center
Sushma AGRAWAL ; Rahul ; Mohammed Naved ALAM ; Neeraj RASTOGI ; Ashish SINGH ; Rajneesh Kumar SINGH ; Anu BEHARI ; Prabhakar MISHRA
Annals of Hepato-Biliary-Pancreatic Surgery 2025;29(1):38-47
		                        		
		                        			 Background:
		                        			s/Aims: Given the high mortality associated with gallbladder cancer (GBC), the efficacy of adjuvant therapy (AT) remains controversial. We audited our data over an 11-year period to assess the impact of AT. 
		                        		
		                        			Methods:
		                        			This study included all patients who underwent curative resection for GBC from 2007 to 2017. Analyses were conducted of clinicopathological characteristics, surgical details, and postoperative therapeutic records. The benefits of adjuvant chemotherapy (CT) or chemoradiotherapy (CTRT) were evaluated against surgery alone using SPSS version 20 for statistical analysis. 
		                        		
		                        			Results:
		                        			The median age of patients (n = 142) was 50 years. The median overall survival (OS) was 93, 34, and 30 months with CT, CTRT, and surgery alone respectively (p = 0.612). Multivariate analysis indicated that only disease stage and microscopically involved margins significantly impacted OS and disease-free survival (DFS). CT showed increased effectiveness across all prognostic subsets, except for stage 4 and margin-positive resections. Following propensity score matching, median DFS and OS were higher in the CT group than in the CTRT group, although the differences were not statistically significant (p > 0.05). 
		                        		
		                        			Conclusions
		                        			Radically resected GBC patients appear to benefit more from adjuvant CT, while CTRT should be reserved for cases with high-risk features. 
		                        		
		                        		
		                        		
		                        	
5.Propensity score analysis of adjuvant therapy in radically resected gallbladder cancers: A real world experience from a regional cancer center
Sushma AGRAWAL ; Rahul ; Mohammed Naved ALAM ; Neeraj RASTOGI ; Ashish SINGH ; Rajneesh Kumar SINGH ; Anu BEHARI ; Prabhakar MISHRA
Annals of Hepato-Biliary-Pancreatic Surgery 2025;29(1):38-47
		                        		
		                        			 Background:
		                        			s/Aims: Given the high mortality associated with gallbladder cancer (GBC), the efficacy of adjuvant therapy (AT) remains controversial. We audited our data over an 11-year period to assess the impact of AT. 
		                        		
		                        			Methods:
		                        			This study included all patients who underwent curative resection for GBC from 2007 to 2017. Analyses were conducted of clinicopathological characteristics, surgical details, and postoperative therapeutic records. The benefits of adjuvant chemotherapy (CT) or chemoradiotherapy (CTRT) were evaluated against surgery alone using SPSS version 20 for statistical analysis. 
		                        		
		                        			Results:
		                        			The median age of patients (n = 142) was 50 years. The median overall survival (OS) was 93, 34, and 30 months with CT, CTRT, and surgery alone respectively (p = 0.612). Multivariate analysis indicated that only disease stage and microscopically involved margins significantly impacted OS and disease-free survival (DFS). CT showed increased effectiveness across all prognostic subsets, except for stage 4 and margin-positive resections. Following propensity score matching, median DFS and OS were higher in the CT group than in the CTRT group, although the differences were not statistically significant (p > 0.05). 
		                        		
		                        			Conclusions
		                        			Radically resected GBC patients appear to benefit more from adjuvant CT, while CTRT should be reserved for cases with high-risk features. 
		                        		
		                        		
		                        		
		                        	
6.CSF1R-Related Adult-Onset Leukoencephalopathy With Axonal Spheroids: A Case Series of Four Asian Indian Patients
Divyani GARG ; Abhishek VAINGANKAR ; Anu GUPTA ; Roopa RAJAN ; Ajay GARG ; Ayush AGARWAL ; Farsana MUSTAFA ; Divya M RADHAKRISHNAN ; Awadh Kishor PANDIT ; Venugopalan Y VISHNU ; Mamta Bhushan SINGH ; Rohit BHATIA ; Achal Kumar SRIVASTAVA
Journal of Movement Disorders 2025;18(2):170-174
		                        		
		                        			 Objective:
		                        			Colony-stimulating factor 1 receptor-related leukoencephalopathy (CSF1R-L) is a rare adult-onset leukoencephalopathy. Reports of CSF1R-L patients from the Indian subcontinent remain limited. We aimed to report four patients with genetically confirmed CSF1R-L from four Asian Indian families and described their clinical, molecular, and radiological features. 
		                        		
		                        			Methods:
		                        			All patients underwent clinical examination, brain magnetic resonance imaging, and whole-exome sequencing to identify causative variants in the CSF1R gene. We also reviewed published reports of Indian patients with CSF1R-L. 
		                        		
		                        			Results:
		                        			The age at enrollment ranged from 34 to 40 years. The duration of symptoms ranged from 11 months to 2 years. The chief clinical phenotype in three patients was a rapidly evolving cognitive-behavioral syndrome combined with atypical parkinsonism, and asymmetrical spastic tetraparesis was observed in one patient. We identified four different variants (three missense variants and one in-frame deletion). Radiological findings revealed white matter involvement and diffusion restriction involving the subcortical white matter and pyramidal tracts. 
		                        		
		                        			Conclusion
		                        			We expand the literature on CSF1R-L patients from India by reporting four new cases. 
		                        		
		                        		
		                        		
		                        	
7.Propensity score analysis of adjuvant therapy in radically resected gallbladder cancers: A real world experience from a regional cancer center
Sushma AGRAWAL ; Rahul ; Mohammed Naved ALAM ; Neeraj RASTOGI ; Ashish SINGH ; Rajneesh Kumar SINGH ; Anu BEHARI ; Prabhakar MISHRA
Annals of Hepato-Biliary-Pancreatic Surgery 2025;29(1):38-47
		                        		
		                        			 Background:
		                        			s/Aims: Given the high mortality associated with gallbladder cancer (GBC), the efficacy of adjuvant therapy (AT) remains controversial. We audited our data over an 11-year period to assess the impact of AT. 
		                        		
		                        			Methods:
		                        			This study included all patients who underwent curative resection for GBC from 2007 to 2017. Analyses were conducted of clinicopathological characteristics, surgical details, and postoperative therapeutic records. The benefits of adjuvant chemotherapy (CT) or chemoradiotherapy (CTRT) were evaluated against surgery alone using SPSS version 20 for statistical analysis. 
		                        		
		                        			Results:
		                        			The median age of patients (n = 142) was 50 years. The median overall survival (OS) was 93, 34, and 30 months with CT, CTRT, and surgery alone respectively (p = 0.612). Multivariate analysis indicated that only disease stage and microscopically involved margins significantly impacted OS and disease-free survival (DFS). CT showed increased effectiveness across all prognostic subsets, except for stage 4 and margin-positive resections. Following propensity score matching, median DFS and OS were higher in the CT group than in the CTRT group, although the differences were not statistically significant (p > 0.05). 
		                        		
		                        			Conclusions
		                        			Radically resected GBC patients appear to benefit more from adjuvant CT, while CTRT should be reserved for cases with high-risk features. 
		                        		
		                        		
		                        		
		                        	
8.CSF1R-Related Adult-Onset Leukoencephalopathy With Axonal Spheroids: A Case Series of Four Asian Indian Patients
Divyani GARG ; Abhishek VAINGANKAR ; Anu GUPTA ; Roopa RAJAN ; Ajay GARG ; Ayush AGARWAL ; Farsana MUSTAFA ; Divya M RADHAKRISHNAN ; Awadh Kishor PANDIT ; Venugopalan Y VISHNU ; Mamta Bhushan SINGH ; Rohit BHATIA ; Achal Kumar SRIVASTAVA
Journal of Movement Disorders 2025;18(2):170-174
		                        		
		                        			 Objective:
		                        			Colony-stimulating factor 1 receptor-related leukoencephalopathy (CSF1R-L) is a rare adult-onset leukoencephalopathy. Reports of CSF1R-L patients from the Indian subcontinent remain limited. We aimed to report four patients with genetically confirmed CSF1R-L from four Asian Indian families and described their clinical, molecular, and radiological features. 
		                        		
		                        			Methods:
		                        			All patients underwent clinical examination, brain magnetic resonance imaging, and whole-exome sequencing to identify causative variants in the CSF1R gene. We also reviewed published reports of Indian patients with CSF1R-L. 
		                        		
		                        			Results:
		                        			The age at enrollment ranged from 34 to 40 years. The duration of symptoms ranged from 11 months to 2 years. The chief clinical phenotype in three patients was a rapidly evolving cognitive-behavioral syndrome combined with atypical parkinsonism, and asymmetrical spastic tetraparesis was observed in one patient. We identified four different variants (three missense variants and one in-frame deletion). Radiological findings revealed white matter involvement and diffusion restriction involving the subcortical white matter and pyramidal tracts. 
		                        		
		                        			Conclusion
		                        			We expand the literature on CSF1R-L patients from India by reporting four new cases. 
		                        		
		                        		
		                        		
		                        	
9.Some results of the standardization of Zidraga-6 capsule Introduction
Myadagbadam U ; Chimedragchaa Ch ; Anu A ; Dejidmaa B ; Erdenechimeg Ch
Mongolian Medical Sciences 2024;209(3):47-55
		                        		
		                        			:
		                        			The “Zidraga-6” prescription, which is widely used in traditional medicine, was 
selected and technologically developed, and formed into capsule medicine. Zidraga-6 
capsule was prepared using six different herbal Capsicum annuum L. Holarrhena 
antidysenterica Wall ex, Atragene sibirica L, Embelia ribes Burm, Terminalia chebula 
Retz, and Kaempferia galanga L. 
		                        		
		                        			Goal:
		                        			This study was conducted to standardize and determine the safety and quality 
parameters of the Zidraga-6 capsule.
		                        		
		                        			Materials and Methods:
		                        			Quality (moisture, total ash) and safety parameters were determined by Mongolian 
National First Pharmacopoeia methods. The content of the main biologically active 
compounds in the Zidraga-6 capsule was identified using TLC. In addition, the 
content of biologically active compounds is determined by UV spectrophotometer 
methods. The results were processed using basic biostatistical methods, calculating 
the arithmetic mean (M), standard deviation (δ), and standard error (m) using the 
SPSS 20.0 program. The ethical approval for the study was obtained by a decision 
of the Ministry of Health - Medical Ethics Review Committee on research on May 23, 
2023 (23/029).
		                        		
		                        			Results:
		                        			The presence of p-methoxycinnamate, gallic acid, oleanolic acid, and capsaicin in the 
Zidraga-6 capsule drug was detected by the TLC method, and their Rf values were 
0.26, 0.24, 0.82, and 0.45, respectively. The average weight of Zidraga-6 capsules 
was 0.4±0.019 g, moisture was 9.63±0.09%, disintegration was 6.48±0.37 minutes, 
dissolution was 94.68±2.85%. The content of methods biologically active compounds 
in the Zidarga-6 capsule was determined total triterpene saponins as 1.89±0.19% by 
UV spectrophotometric methods.
		                        		
		                        			Conclusion
		                        			We determined quality and safety parameters of the Zidraga-6 capsule were defined 
and the Mongolian National Pharmacopoeia monograph’s draft for the Zidraga-6  
capsule was developed.
		                        		
		                        		
		                        		
		                        	
10.Adjuvant carboplatin and paclitaxel with “sandwich” method radiotherapy for stage III or IV endometrial cancer:long-term follow-up at a singleinstitution
Anu CHINNADURAI ; Daniel BREADNER ; Ziad BALOUSH ; Ana Elisa LOHMANN ; Morgan BLACK ; David D’SOUZA ; Stephen WELCH
Journal of Gynecologic Oncology 2024;35(2):e16-
		                        		
		                        			 Objective:
		                        			To evaluate disease-free survival (DFS) and overall survival (OS) associated with adjuvant carboplatin and paclitaxel chemotherapy interposed with radiation for advanced endometrial cancer. 
		                        		
		                        			Methods:
		                        			This is a cohort study of adult women with stage III or IV endometrial cancer treated at a single institution, between April 2002 and October 2017. Tumor and treatment characteristics were recorded. Treatment consisted of 4 cycles of intravenous paclitaxel and carboplatin every 3 weeks, followed by external beam radiotherapy to the pelvis (45–50 Gy), and another 2 cycles of chemotherapy. One cohort of patients were prospectively enrolled from 2002 through 2006 and an additional cohort from 2007 to 2017, which was retrospectively analyzed. Primary endpoints for this study were DFS and OS rates which were calculated using Cox regression models. 
		                        		
		                        			Results:
		                        			Eighty-two patients with a median age of 66.5 years (range, 35–83 years) were included. Median follow-up was 46 months (range, 9–196 months). Most patients had stage IIIC disease (62.2%) and serous carcinoma histology (46.3%). Median OS was 146 months and median DFS was 71 months. A 5-year OS and DFS were 64.9% and 55.7%, respectively.Age >60 years subgroup was at a significantly higher risk of DFS event or death. Histological subtype, location of positive nodes, and cancer stage (IIIa vs. higher stage) did not correlate to a higher risk of recurrence or death. 
		                        		
		                        			Conclusion
		                        			Long term follow-up and a larger population confirm that the chemoradiotherapy sandwich method yields favorable outcomes in patients with high-risk endometrial cancer. 
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail